Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detection and Quantification of Isotope Uptake in PET Scans
May 16 2024 - 8:15AM
Claritas HealthTech Ltd, a company specializing in state-of-the-art
image enhancement, reconstruction, and AI solutions for the medical
industry, is pleased to announce the completion of
iPETcertum™, its new software device for automated
lesion detection, delineation, and automatic quantification of
isotope uptake in PET, PET-CT/MRI scans.
iPETcertum™ extends the functionality of
Claritas iPET™, an SaMD (Software as a Medical
Device) for accelerated and reduced isotope scans for PET,
PET-CT/MRI. Claritas iPET™ enables reducing scan time and reducing
contrast dose, while yielding diagnostic quality images.
iPETcertum™, provides the additional capability of automated and
accurate detection and quantification of isotope uptake in tissues
and organs quantified by SUV, SUVmax, and volume values.
iPETcertum™ provides clinicians the ability to locate lesions
automatically by values specified by them.
Mr. Chetan Baxi, Co-founder, and Director of
Claritas, commented, “The
completion of iPETcertum™ marks a significant
milestone of our R&D with our clinical partners. This software
augments the clinician’s workflow and enables faster and more
accurate reporting. This in turn allows the doctors to focus more
of their time on patient care."
Claritas iPET™ is FDA 510k cleared and is
commercially available, the company expects iPETcertum™ to obtain
FDA 510k clearance by Q4, 2024. The software is agnostic to
equipment brand/models and image types and can be rapidly deployed
on site or accessed remotely. The functionality and capability of
both software devices will be featured at the SNMMI Annual Meeting
in June 2024 in Toronto.
Media Contact:
Devika Dutt
d.d@claritasco.com
About Claritas
HealthTech Limited
Claritas conducts research and development in
the fields of image enhancement, machine vision and artificial
intelligence (“AI”) with a focus on medical image processing and
AI-assisted interpretation and diagnostics. Claritas aims to
transform the diagnostics industry with powerful and effective
software products created using image enhancement and AI
technology, to enable and assist doctors in medical diagnostics.
Claritas AI-assisted diagnostic tools are fully compliant with
HIPAA, PDPA and GDPR requirements. For more information, please
visit www.claritashealthtech.com.